C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/385 (2006.01) A61K 39/395 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01) C07K 16/22 (2006.01) C07K 16/46 (2006.01) C12N 5/16 (2006.01) C12N 15/63 (2006.01) C12P 21/08 (2006.01) G01N 33/53 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2583910
Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
L'invention concerne des agents de liaison spécifiques, tels que des anticorps entièrement humains qui se lient à l'angiopoïétine-2. Cette invention a aussi trait à des fragments à chaîne lourde, à des fragments à chaîne légère et à des régions déterminant la complémentarité (CDR) des anticorps, ainsi qu'à des méthodes d'élaboration et d'utilisation desdits anticorps.
Graham Kevin
Oliner Jonathan Daniel
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Angiopoietin-2 specific binding agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiopoietin-2 specific binding agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiopoietin-2 specific binding agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1935780